Cardlytics Q2 2021 Earnings Report
Key Takeaways
Cardlytics announced its Q2 2021 financial results, with revenue increasing by 109% year-over-year to $58.9 million and billings increasing by 116% to $85.3 million. However, the company reported a net loss attributable to common stockholders of $(47.3) million, or $(1.43) per diluted share.
Revenue increased by 109% year-over-year to $58.9 million.
Billings increased by 116% year-over-year to $85.3 million.
Gross profit increased by 193% year-over-year to $23.2 million.
Net loss attributable to common stockholders was $(47.3) million, or $(1.43) per diluted share.
Cardlytics
Cardlytics
Forward Guidance
Cardlytics anticipates billings, revenue, and adjusted contribution to be in the following ranges for Q3 2021: Billings $85.0 - $95.0 million, Revenue $57.0 - $66.0 million, Adjusted contribution $27.0 - $32.0 million.